5 February 2019
According to Communications Biology the featured reviewers are those who have:

The editors of Communications Biology recognize Peter Friedl, theme Cancer development and immune defense, as reviewer of the month for his exceptional contributions to peer review.
According to Communications Biology the featured reviewers are those who have:
- made a significant and positive contribution to the peer review process, regardless of whether the paper was eventually accepted by the journal;
- taken both a broad and detailed view of the paper;
- demonstrated professionalism and compassion in their reviews; and
- provided comments that truly help the authors to improve their work.
Related news items

NWO open call GROOT grant for Peter Friedl
24 February 2020 Peter Friedl, theme Cancer development and immune defense, received a 300,000 EUR grant within the NWO-GROOT consortium "Active matter of cancer metastasis" to identify the mechanisms of collective metastasis in breast cancer. read more
p120-catenin-dependent collective brain infiltration by glioma cell networks
7 January 2020 Pavlo Gritsenko and Peter Friedl, theme Cancer development and immune defense, report in Nature Cell Biology, that glioma cells infiltrate the brain by a collective network mechanism, which critically depends on p120 catenin. p120 thus represents a potential target to combat glioma. read more
Collective cancer invasion forms an integrin-dependent radioresistant niche
29 October 2019 Anna Häger and Peter Friedl, theme Cancer development and immune defense, identified a new niche of cancer cell survival and developed an integrin inhibition therapy to overcome resistance. They have published their results in JEM. read more
Three VIDI grants for RIMLS researchers
24 May 2019 Matthijs Jore, Daniele Tauriello and Johannes Textor are each to receive up to 800,000 euros to develop an innovative research theme and to build up their own research group. NWO is awarding the Vidi grant as part of the Innovational Research Incentives Scheme. read more
Radium 223-mediated zonal cytotoxicity of prostate cancer in bone
21 January 2019 Peter Friedl, theme Cancer development and immune defense, and colleagues published in the Journal of National Cancer Institute about the prevention of early bone cancer. read more